Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zuoshu Qin"'
Autor:
Jingjie Li, Zuoshu Qin, Yunqi Li, Baozhu Huang, Qimeng Xiao, Peiqin Chen, Yifan Luo, Wenxin Zheng, Tao Zhang, Zhenbo Zhang
Publikováno v:
Advanced Science, Vol 11, Iss 23, Pp n/a-n/a (2024)
Abstract The progestin regimen is one of the main therapeutic strategies for women with endometrial cancer who undergo conservative management. Although many patients respond well to initial therapy, progestin‐refractory disease inevitably emerges,
Externí odkaz:
https://doaj.org/article/e1882ba92ef7494fac6c6ee35030432d
Autor:
Wen Li, Yiqing Xu, Zuoshu Qin, Di Sun, Yong Liu, Mingzhu Bai, Zhenbo Zhang, Wenxin Zheng, Qi-meng Xiao, Yuan Xu
Publikováno v:
Cancer Letters. 526:311-321
Progestin resistance is a critical factor that prevents patients with endometrial cancer (EC) from receiving conservative therapy. However, the etiology remains elusive. Cancer stem cells (CSCs) may be a contributing factor to progestin resistance in
Autor:
Zuoshu Qin, Huiting Zhu, Qiuju Zhang, Youji Feng, Yue Wang, Meiyan Hu, Jing Yu, Wenxin Zheng, Yue Fu, Youheng Wei, Hong Liao, Jingjie Li, Baozhu Huang, Sufang Wu, Di Sun, Zhenbo Zhang, Xiong Chen
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 102(12)
BackgroundProgestin resistance is the main obstacle for the conservative therapy to maintain fertility in women with endometrial hyperplasia and cancer. Up to 30% of endometrial cancers fail to respond to progestin, a rate that has not significantly